MedicaidPrior AuthMedium impact
Gamifant® (emapalumab-lzsg) (Revised)
Humana·LA · Hematology, Oncology, Pediatrics·Medicaid
We identified it
Jul 1, 2026
Summary
This is a revised Prior Authorization policy for Gamifant® (emapalumab-lzsg) affecting Louisiana Medicaid members. The policy update requires billing teams to verify current prior authorization requirements before submitting claims for this medication. Without access to the full policy content, specific changes cannot be determined, but this fresh update (1 day old) should be reviewed immediately for any workflow modifications.
Action Required
Immediately: Billing team must access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a56a5d4 to review the revised prior authorization requirements for Gamifant® (emapalumab-lzsg). Verify the HCPCS code for this medication, update billing system rules to reflect any new or changed prior authorization triggers, and communicate changes to providers and clinical staff. Failure to follow updated prior auth requirements will result in claim denials for Louisiana Medicaid members.